Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

Jericho Sciences

other

www.jerichosciences.comDurham (RTP), North Carolina, United States
13 profile visits

About

Jericho Sciences is developing small molecule antiviral therapeutics to address both chronic virus infections and potential emerging viruses, with current focus on a curative approach for clearing chronic Hepatitis B Virus infection — a leading cause of all liver diseases — with morbidities and mortalities affecting an estimated 3.6 million people in the EU and UK (300 million globally).

What is your business/industry sector?

Biotech, Pharma and Cosmetics

Representatives

Heidi Kay

CEO/Founder

Jericho Sciences